BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

NATIONAL VIRAL HEPATITIS ROUNDTABLE — Receipts Report

LD-2 disclosure · 1st Quarter - Report

NATIONAL VIRAL HEPATITIS ROUNDTABLE

via HART HEALTH STRATEGIES

1st Quarter (Jan 1 - Mar 31) · 2012Posted Apr 20, 2012Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: NATIONAL VIRAL HEPATITIS ROUNDTABLE
Description: Health care
Location: Georgia · United States of America

Registrant

Firm: HART HEALTH STRATEGIES
Description: Healthcare Consulting Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Monitoring health care regulations and legislation
LobbyistsVICKI HART · SUSAN RAMTHUN · EMILY GRAHAM
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.